A Comparative Study on the Recovery Quality of Anesthesia with Propofol and Ciprofol in Patients Undergoing Endoscopic Pituitary Tumor Surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400089108

Enrollment

Unknown

Registered

2024-09-02

Start date

2024-09-10

Completion date

Unknown

Last updated

2025-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pituitary tumor

Interventions

Ciprofol group:Cyclopofol intravenous anesthesia

Propofol group:Intravenous anesthesia with propofol

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.18~65 years old; ASA1-3 level; 2. Patients undergoing endoscopic resection of nasohypophysial tumors.

Exclusion criteria

Exclusion criteria: 1. Heart, lung, liver and kidney dysfunction. 2. Obese BMI greater than 32.5. 3. People who are allergic to research drugs. 4. It is not expected that the tracheal catheter can be removed after surgery.

Design outcomes

Primary

Measure	Time frame
Awakening quality during the awakening period: awakening time, extubation time, modified Aldrete score, occurrence during the awakening period;	—

Secondary

Measure	Time frame
Postoperative delirium: CAM-ICU scale score on day 1 and 3 after surgery;Perioperative neurocognitive impairment: MMSE and MoCA scale scores on the 1st and 3rd day after surgery;Postoperative rehabilitation: QoR-40 score on the 1st and 3rd day after surgery;Intraoperative knowledge: Improved Brice questionnaire on day 1 after surgery;	—

Countries

China

Contacts

Public ContactCui Weihua

Department of Anesthesiology, Beijing Tian Tan Hospital, Capital Medical University

13651315600@139.com+86 136 5131 5600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026